Koob GF - Search Results

1

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.

Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M. Rodríguez de Fonseca F, et al. Among authors: koob gf. J Pharmacol Exp Ther. 1996 Jan;276(1):56-64. J Pharmacol Exp Ther. 1996. PMID: 8558457

2

Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.

Navarro M, Carrera MR, Del Arco I, Trigo JM, Koob GF, Rodríguez de Fonseca F. Navarro M, et al. Among authors: koob gf. Eur J Pharmacol. 2004 Oct 6;501(1-3):235-7. doi: 10.1016/j.ejphar.2004.08.022. Eur J Pharmacol. 2004. PMID: 15464083

3

Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.

Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF. Menzaghi F, et al. Among authors: koob gf. J Pharmacol Exp Ther. 1994 May;269(2):564-72. J Pharmacol Exp Ther. 1994. PMID: 8182523

4

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.

Rodríguez de Fonseca F, Carrera MR, Navarro M, Koob GF, Weiss F. Rodríguez de Fonseca F, et al. Among authors: koob gf. Science. 1997 Jun 27;276(5321):2050-4. doi: 10.1126/science.276.5321.2050. Science. 1997. PMID: 9197270

5

Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.

Rodríguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, Navarro M. Rodríguez de Fonseca F, et al. Among authors: koob gf. Zhongguo Yao Li Xue Bao. 1999 Dec;20(12):1109-14. Zhongguo Yao Li Xue Bao. 1999. PMID: 11189201 Free article.

6

The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.

Rodríguez De Fonseca F, Rubio P, Martín-Calderón JL, Caine SB, Koob GF, Navarro M. Rodríguez De Fonseca F, et al. Among authors: koob gf. Eur J Pharmacol. 1995 Feb 14;274(1-3):47-55. doi: 10.1016/0014-2999(94)00708-f. Eur J Pharmacol. 1995. PMID: 7768280

7

Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.

Inoue K, Valdez GR, Reyes TM, Reinhardt LE, Tabarin A, Rivier J, Vale WW, Sawchenko PE, Koob GF, Zorrilla EP. Inoue K, et al. Among authors: koob gf. J Pharmacol Exp Ther. 2003 Apr;305(1):385-93. doi: 10.1124/jpet.102.047712. J Pharmacol Exp Ther. 2003. PMID: 12649393

8

Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.

Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF. Zorrilla EP, et al. Among authors: koob gf. J Pharmacol Exp Ther. 2004 Sep;310(3):1027-34. doi: 10.1124/jpet.104.068676. Epub 2004 Apr 28. J Pharmacol Exp Ther. 2004. PMID: 15115804

9

Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats.

Menzaghi F, Heinrichs SC, Merlo-Pich E, Tilders FJ, Koob GF. Menzaghi F, et al. Among authors: koob gf. Neurosci Lett. 1994 Feb 28;168(1-2):139-42. doi: 10.1016/0304-3940(94)90435-9. Neurosci Lett. 1994. PMID: 8028766

10

The role of CRF in behavioral aspects of stress.

Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT, Koob GF. Heinrichs SC, et al. Among authors: koob gf. Ann N Y Acad Sci. 1995 Dec 29;771:92-104. doi: 10.1111/j.1749-6632.1995.tb44673.x. Ann N Y Acad Sci. 1995. PMID: 8597448 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters